Perturbation of the preterm human immune system in early life
Authors:
- Benjamin A. FensterheimBFBenjamin A. Fensterheim
- Michelle L. McKeagueMMMichelle L. McKeague
- Divij MathewDMDivij Mathew
- Ajinkya PattekarAPAjinkya Pattekar
- Matthew LeeMLMatthew Lee
- Zahabia RangwalaZRZahabia Rangwala
- Sean NastaSNSean Nasta
- Macy C. KeeMKMacy C. Kee
- Cynthia ClendeninCCCynthia Clendenin
- Zachary MartinezZMZachary Martinez
- Caroline DiorioCDCaroline Diorio
Open Access
- 21 April 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (11)
Abstract
Although inflammatory complications are common in preterm infants, the effects of these conditions on neonatal immune development remain poorly defined. We therefore investigated whether severe bronchopulmonary dysplasia (BPD) and systemic infection, 2 major complications of prematurity, produce distinct immune signatures and change immune composition over time. We performed longitudinal high-dimensional immune profiling of residual whole blood from 38 preterm infants sampled every 2 weeks, along with 10 term infants at birth. Preterm infants with severe BPD showed a progressive increase in Th17-polarized CD4 + T cells, neutrophils, and Th17-related cytokines compared with age-matched infants with moderate BPD. In contrast, some preterm infants with systemic bacterial or viral infections mounted exceptionally robust CD8 + , CD4 + , and γδ T cell responses, with oligoclonal expansion, terminal differentiation, and coordinated plasma cytokine shifts that persisted well beyond resolution of infection. These findings demonstrate that different preterm comorbidities imprint the neonatal immune system in divergent ways. Thus, comprehensive and longitudinal immune profiling may not only identify connections between clinical inflammatory complications and underlying immune pathways but also reveal potential targets for intervention.Keywords
Funding Information
- American Academy of Pediatrics (Marshall Klaus Award)
- Thrasher Research Fund (Early Career Research Award)
- National Institutes of Health (AI155577,AI115712,AI117950,AI108545,AI082630,AI149680,HL145754)
This publication has 84 references indexed in Scilit:
- Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary DysplasiaThe American Journal of Pathology, 2024
- Effect of acute histologic chorioamnionitis on bronchopulmonary dysplasia and mortality rate among extremely low gestational age neonates: A retrospective case–control studyInternational Journal of Gynecology & Obstetrics, 2023
- Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm InfantsJAMA Network Open, 2022
- A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID‐19Cytometry Part A, 2021
- Preterm birth and sustained inflammation: consequences for the neonateSeminars in Immunopathology, 2020
- Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversiesAutoimmunity Reviews, 2020
- Infections in Early Life and Development of Type 1 DiabetesJAMA, 2016
- Developmental regulation of Th17‐cell capacity in human neonatesEuropean Journal of Immunology, 2011
- CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORCEuropean Journal of Immunology, 2010
- A Phenotypic Study of CD8+ Lymphocyte Subsets in Infants Using Three-Color Flow CytometryClinical Immunology and Immunopathology, 1994